Work overview

Section 22 of 37

DOSAGE FORM

Mechanistic insights into probiotic modulation of the gut–immune axis and their role as sustainable antibiotic alternatives in poultry production: An integrative review

Andreas Berny Yulianto, Aswin Rafif Khairullah, Widya Paramita Lokapirnasari, Mohammad Anam Al-Arif, Zulfi Nur Amrina Rosyada, Emy Koestanti Sabdoningrum, Bodhi Agustono, Mirni Lamid, Kartika Purnamasari, Bima Putra Pratama, Riza Zainuddin Ahmad, Wasito Wasito, Saifur Rehman, and Muhammad Aviv Firdaus · 2026

Contents

Section 22 of 37

  1. 01INTRODUCTION
  2. 02REVIEW METHODOLOGY
  3. 03BASIC CONCEPTS OF PROBIOTICS IN POULTRY
  4. 04DEFINITION OF PROBIOTICS
  5. 05TYPES AND SOURCES OF PROBIOTICS FOR POULTRY
  6. 06STRAIN-SPECIFIC EFFECTS AND QUANTITATIVE EVIDENCE
  7. 07GENERAL MECHANISMS OF PROBIOTICS IN THE DIGESTIVE TRACT
  8. 08IMMUNE SYSTEM IN POULTRY
  9. 09MUCOSAL IMMUNITY (GALT)
  10. 10INNATE IMMUNITY
  11. 11ADAPTIVE IMMUNITY
  12. 12GUT–IMMUNE AXIS RELATIONSHIP IN POULTRY
  13. 13THE EFFECT OF PROBIOTICS ON POULTRY IMMUNITY
  14. 14PROBIOTICS IN INCREASING INNATE IMMUNITY
  15. 15PROBIOTICS AND ADAPTIVE IMMUNITY
  16. 16EFFECTS ON MAJOR IMMUNE ORGANS
  17. 17PROBIOTICS IN REDUCING STRESS AND INFLAMMATION
  18. 18PROBIOTIC–MICROBIOTA INTERACTIONS IN SUPPORTING IMMUNITY
  19. 19THE EFFECT OF PROBIOTICS ON DISEASE RESISTANCE IN POULTRY
  20. 20FACTORS THAT INFLUENCE THE SUCCESS OF PROBIOTICS
  21. 21DOSAGE AND DURATION OF ADMINISTRATION
  22. 22DOSAGE FORM
  23. 23STABILITY AND RESISTANCE TO PH AND TEMPERATURE
  24. 24COMBINATION WITH PREBIOTICS (SYNBIOTICS)
  25. 25BACTERIAL STRAINS USED
  26. 26IN OVO AND EARLY-LIFE PROBIOTIC ADMINISTRATION
  27. 27CHALLENGES AND LIMITATIONS OF PROBIOTIC USE
  28. 28IMPLICATIONS FOR THE POULTRY INDUSTRY
  29. 29MARKET TRENDS AND REGIONAL ADOPTION PATTERNS
  30. 30SHORT-TERM APPLICABLE STRATEGIES FOR INDUSTRY IMPLEMENTATION
  31. 31ILLUSTRATIVE COMMERCIAL CASE EXAMPLES
  32. 32LONG-TERM RESEARCH AND DEVELOPMENT GOALS
  33. 33EMERGING ANALYTICAL APPROACHES
  34. 34FURTHER RESEARCH DIRECTIONS
  35. 35CONCLUSION
  36. 36GENERATIVE ARTIFICIAL INTELLIGENCE DECLARATION
  37. 37AUTHORS’ CONTRIBUTIONS
Text size
Work overview

Section 22 of 37

DOSAGE FORM

Andreas Berny Yulianto, Aswin Rafif Khairullah, Widya Paramita Lokapirnasari, Mohammad Anam Al-Arif, Zulfi Nur Amrina Rosyada, Emy Koestanti Sabdoningrum, Bodhi Agustono, Mirni Lamid, Kartika Purnamasari, Bima Putra Pratama, Riza Zainuddin Ahmad, Wasito Wasito, Saifur Rehman, and Muhammad Aviv Firdaus · about 3 minutes

The dosage form of a probiotic is a crucial factor in determining the stability, viability, and biological effectiveness of the microorganism when consumed by poultry [224]. Probiotics are available in various forms, such as liquid solutions, capsules, or freeze-dried, each with its own advantages regarding storage, resistance to digestive tract conditions, and ease of application in feed [225].

In commercial practice, the choice of dosage form should also consider economic efficiency, storage logistics, compatibility with feed mill infrastructure, and potential losses during pelleting [12]. Heat-stable spore-forming strains (e.g., Bacillus spp.) may reduce viability losses during feed processing, thereby improving cost-effectiveness compared to heat-sensitive strains requiring protective technologies [226].

In commercial poultry production, probiotic inclusion levels commonly range from 10⁶ to 10⁹ CFU/g of feed, which is equivalent to approximately 10⁷–10⁹ CFU/bird/day depending on feed intake and bird age [227]. Lower inclusion rates (10⁶ CFU/g) are typically used for maintenance of gut microbial balance, whereas higher levels (10⁸–10⁹ CFU/g) are often applied during early-life stages, periods of stress, vaccination, or pathogen challenge. However, optimal dosage remains strain-specific and should be validated under field conditions [222].

Liquid probiotics are generally suspensions of live bacteria in a culture medium, allowing them to be added directly to feed or drinking water. This format simplifies distribution and dosage adjustments, but has limitations related to shelf life and susceptibility to high temperatures and oxygen exposure [208].

Probiotics in capsule form provide physical protection against the acidic environment of the stomach while simplifying dosage adjustments. These capsules typically contain live bacterial cells coated in a protective matrix, increasing the likelihood that the bacteria will remain viable once they reach the intestines [228]. The capsule format also simplifies implementation in long-term supplementation programs.

Freeze-drying is the most commonly used preservation method for poultry. This process carefully removes water from the bacterial culture, keeping the cells viable in a dry, stable state for long-term storage [229]. Advantages of this method include resistance to high temperatures during feed mixing and a longer shelf life, while maintaining bacterial viability after rehydration in the digestive tract [230].

Recent advances highlight the use of nanotechnology and advanced delivery platforms to enhance probiotic stability, bioavailability, and immune effects [231]. Nanoparticle-based encapsulation protects probiotic cells from heat, oxygen, and stomach acidity, ensuring higher survival rates and improved colonization of the gut [232]. Such formulations have been shown in 2025 trials to improve villus height, enhance mucosal immunity, reduce mortality, and support growth performance under commercial conditions [233]. Water-delivered microencap-sulated probiotics allow precise dosing, rapid gut delivery, and minimal loss during feed processing.

Regarding duration of administration, short-term supplementation (7–14 days) is often applied around critical periods such as post-hatch, feed transition, vaccination, or disease challenge to enhance immune responsiveness [234]. In contrast, continuous supplementation throughout the production cycle (e.g., 4–6 weeks in broilers or extended periods in layers) has been associated with more stable gut microbiota establishment, improved feed efficiency, and sustained immune modulation [15]. Early-life administration, particularly during the first week post-hatch, appears especially important for promoting immune organ development and long-term microbiota stability [235].

Dose–response studies generally indicate a positive response up to an optimal threshold, beyond which benefits plateau and, in some cases, excessive doses may disturb microbial balance [131]. This suggests a non-linear dose–response relationship rather than a simple “more is better” effect. Therefore, probiotic application should consider both minimal effective dose and economic efficiency, ideally supported by controlled trials or farm level performance monitoring [80].

The choice of probiotic dosage form should be tailored to the intended use, the age of the birds, environmental conditions, and the method of administration [236]. Using the right dosage form ensures the viability of the probiotic bacteria, optimal immunomodulatory effects, and maximizes the benefits for digestive health and poultry performance [237].